1. Schmidt B, Roberts RS, Davis P, et al.; Caffeine for Apnea of Prematurity Trial Group. Caffeine therapy for apnea of prematurity. N Engl J Med.2006;354(20):2112-2121.
2. Stevenson DK. On the caffeination of prematurity. N Engl J Med. 2007;357(19):1967-1968.
3. Schmidt B, Roberts RS, Davis P, et al.; Caffeine for Apnea of Prematurity Trial Group. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357(19):1893-1902
4. Schmidt B, Anderson PJ, Doyle LW, et al.; Caffeine for Apnea of Prematurity (CAP) Trial Investigators. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA. 2012;307(3):275-282.
5. Davis PG, Schmidt B, Roberts RS, et al.; Caffeine for Apnea of Prematurity Trial Group. Caffeine for Apnea of Prematurity Trial: benefits may vary in subgroups. J Pediatr. 2010;156(3):382-387.
6. Patel RM, Leong T, Carlton DP, Vyas-Read S. Early caffeine therapy and clinical outcomes in extremely preterm infants. J Perinatal. 2013;33(2):134-140.
7. Taha D, Kirby S, Nawab U, Dysart KC, Gene L, Greenspan JS, Aghai ZH. Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants. J Matern Fetal Neonatal Med 2014; 27: 1698-702.
8. Association of Early Caffeine Administration and Neonatal Outcomes in Very Preterm Neonates. Abhay Lodha, MD, MSc; Mary Seshia, MBChB; Douglas D. McMillan, MD; Keith Barrington, MD; Junmin Yang, MSc; Shoo K. Lee, MD, Ph.D.; Prakesh S. Shah, MD, MSc; for the Canadian Neonatal Network JAMA Pediatric. 2015;169(1):33-38. doi:10.1001/jamapediatrics.2014.2223
9. Dobson NR, Patel RM, Smith PB, Kuehn DR, Clark J, Vyas-Read S, Her- ring A, Laughon MM, Carlton D, Hunt CE. Trends in caffeine use and the association between clinical outcomes and timing of therapy in very low birth weight infants. J Pediatr 2014; 164: 992-8. e3.
10. Henderson-Smart DJ, De Paoli AG. Prophylactic methylxanthine for prevention of apnea in preterm infants. Cochrane Database Syst Rev 2010: CD000432.
11.Spitzer AR. Evidence-based methylxanthine use in the NICU. Clin Perinatal. 2012;39(1):137-148
12. Bauer J, Maier K, Linder Kamp O, Hentschel R. Effect of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea. Pediatrics. 2001;107(4):660-663.
13. Gerben B. Keijzers, Bastiaan E. De Galan, Cees J. Tack, and Paul Smits. Caffeine Can Decrease Insulin Sensitivity in Humans. Diabetes Care 2002 Feb; 25(2): 364-369.
14. Jie Ping, You-ying Lei, Lian Liu, Ting-ting Wang, Ying-hong Feng, Hui Wang,
Inheritable stimulatory effects of caffeine on steroidogenic acute regulatory protein expression and cortisol production in human adrenocortical cells, Chemico-Biological Interactions, Volume 195, Issue 1,2012,Pages 68-75.
15. Amy Yang, Abraham A. Palmer, Harriet Wit. Genetics of caffeine consumption and responses to caffeine. Psychopharmacology, 2010, Volume 211, Number 3, Page 245